[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 59, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 62, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 57, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 68, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Luis  Sanay C.F.A.", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 54, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 62, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.225, "open": 9.1, "dayLow": 9.04, "dayHigh": 9.53, "regularMarketPreviousClose": 9.225, "regularMarketOpen": 9.1, "regularMarketDayLow": 9.04, "regularMarketDayHigh": 9.53, "payoutRatio": 0.0, "beta": 2.582, "trailingPE": 4.5771146, "forwardPE": -26.562723, "volume": 3410294, "regularMarketVolume": 3410294, "averageVolume": 4442356, "averageVolume10days": 3810550, "averageDailyVolume10Day": 3810550, "bid": 9.17, "ask": 9.25, "bidSize": 3, "askSize": 3, "marketCap": 1494990720, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 10.64, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 1.4042073, "fiftyDayAverage": 7.7638, "twoHundredDayAverage": 7.5911, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 983236736, "profitMargins": 0.32099, "floatShares": 140199258, "sharesOutstanding": 162498995, "sharesShort": 51181637, "sharesShortPriorMonth": 54721714, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.315, "heldPercentInsiders": 0.08793, "heldPercentInstitutions": 0.6968, "shortRatio": 8.37, "shortPercentOfFloat": 0.3161, "impliedSharesOutstanding": 162498995, "bookValue": -0.964, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 341744992, "trailingEps": 2.01, "forwardEps": -0.34635, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.924, "enterpriseToEbitda": 2.176, "52WeekChange": 0.054545403, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 9.2, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.88889, "targetMedianPrice": 11.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 762894016, "totalCashPerShare": 4.695, "ebitda": 451828000, "totalDebt": 251140000, "quickRatio": 1.854, "currentRatio": 2.267, "totalRevenue": 1064651008, "revenuePerShare": 6.595, "returnOnAssets": 0.18014, "grossProfits": 632619008, "freeCashflow": -455231136, "operatingCashflow": -378323008, "revenueGrowth": -0.166, "grossMargins": 0.59419996, "ebitdaMargins": 0.42439, "operatingMargins": -1.12684, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "marketState": "CLOSED", "postMarketChangePercent": -0.3239072, "postMarketPrice": 9.1702, "postMarketChange": -0.029799461, "regularMarketChange": -0.0250006, "regularMarketDayRange": "9.04 - 9.53", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4442356, "fiftyTwoWeekLowChange": 4.1899996, "fiftyTwoWeekLowChangePercent": 0.8363272, "fiftyTwoWeekRange": "5.01 - 10.64", "fiftyTwoWeekHighChange": -1.4400005, "fiftyTwoWeekHighChangePercent": -0.1353384, "fiftyTwoWeekChangePercent": 5.4545403, "dividendDate": 1557446400, "corporateActions": [], "postMarketTime": 1771635411, "regularMarketTime": 1771621200, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.271009, "regularMarketPrice": 9.2, "earningsTimestamp": 1772112600, "earningsTimestampStart": 1772112600, "earningsTimestampEnd": 1772112600, "earningsCallTimestampStart": 1772112600, "earningsCallTimestampEnd": 1772112600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.01, "epsForward": -0.34635, "epsCurrentYear": 2.0204, "priceEpsCurrentYear": 4.5535536, "fiftyDayAverageChange": 1.4361997, "fiftyDayAverageChangePercent": 0.18498668, "twoHundredDayAverageChange": 1.6088996, "twoHundredDayAverageChangePercent": 0.2119455, "priceToBook": -9.543569, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]